CD14 and Alzheimer disease: Available CSF single-cell data from age-matched and Alzheimer's disease (AD) patients served as additional controls.<h4>Results</h4>Proportions of CD14<sup>+</sup> monocytes in CSF are increased in PMS and correlated with clinical surrogate markers of progression.